Veterinary Medicines

Benazecare Flavour 5 mg Tablets for Dogs and Cats

Authorised
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
Benazecare Flavour 5 mg Tablets for Dogs and Cats
Benazecare Flavour 5 mg Tabletten für Hunde und Katzen
Active substance:
  • Benazepril hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    5.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 14 tablets.
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 28 tablets.
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 56 tablets.
  • Aluminium/aluminium blister packs containing 14 tablets, packed in a cardboard box with a package leaflet. BenazecareFlavour 5 mg tablets are supplied in packs of 140 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401084.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0452/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 6/07/2025
Download
German (PDF)
Published on: 30/09/2025
Download